The role of calcium and vitamin D in the management of osteoporosis

Bone

Volumn 42, Issue 2, 2008, Pages 246-249

  Rizzoli, R ^a   Boonen, S ^b   Brandi, M L ^c   Burlet, N ^d   Delmas, P ^e   Reginster, J Y ^f  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF FLORENCE   (Italy)

^d International Osteoporosis Foundation   (Switzerland)

^e UNIVERSITÉ LYON 1   (France)

^f On behalf of the European Soc for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis ^*  (Belgium)

Author keywords

Calcium; Fracture; Menopause; Osteoporosis; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ARTICLE; DIET SUPPLEMENTATION; DRUG EFFICACY; FRAGILITY FRACTURE; HEALTH ECONOMICS; HUMAN; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATIENT COMPLIANCE; POSTMENOPAUSE;

ANIMALS; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; HUMANS; OSTEOPOROSIS; POSTMENOPAUSE; VITAMIN D;

EID: 38049066362     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.10.005     Document Type: Article

References (40)

1. North American Menopause Society. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 3 (2006) 862-877
2. Winzenberg T., Shaw K., Fryer J., et al. Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials. BMJ 333 (2006) 775
3. Jackson R.D., LaCroix A., Gass M., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 (2006) 669-683
4. Prince R.L., Devine A., Dhaliwal S.S., et al. Effects of calcium supplementation on clinical fracture and bone structure. Arch Intern Med 166 (2006) 869-875
5. 3) for prevention of fractures in primary care. BMJ 330 (2005) 1003
6. Boonen S., Lips P., Bouillon R., et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 92 (2007) 1415-1423
7. 3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 13 (2002) 257-264
8. Sahota O., Mundey M.K., San P., et al. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone 35 (2004) 312-319
9. Dawson-Hughes B., Heaney R.P., Holick M.F., et al. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
10. Bruyère O., Malaise O., Neuprez A., et al. European postmenopausal women have high prevalence of vitamin D inadequacy. Arthritis Rheum 54 Suppl S585 (2006)
11. Malabanan A., Veronikis I.E., and Holick M.F. Redefining vitamin D insufficiency. Lancet 351 (1998) 805-806
12. Chapuy M.C., Arlott M.E., Duboeuf F., et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327 (1992) 1637-1642
13. Dawson-Hughes B., Harris S.S., Krall E.A., et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337 (1997) 670-676
14. Larsen E.R., Mosekilde L., and Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents : a pragmatic population-based 3-year intervention study. J Bone Miner Res 19 (2004) 370-378
15. 3. J Clin Invest 76 (1985) 1536-1538
16. Holick M.F., Matsuoka L.Y., Wortsman J., et al. Age, vitamin D, and solar ultraviolet. Lancet 2 (1989) 1104-1105
17. Ireland P., and Fordtran J.S. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J Clin Invest 52 (1973) 2672-2681
18. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., et al. Fracture prevention with vitamin D supplementation. JAMA 293 (2005) 2257-2264
19. Heikinheimo R.J., Inkovaara J.A., Harju E.J., et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51 2 (1992) 105-110
20. Bischoff-Ferrari H.A. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18 (2007) 401-407
21. 3 and calcium for secondary prevention of law-trauma fractures in elderly people (randomised evaluation of calcium or Vitamin D, record): a randomised placebo-controlled trial. Lancet 365 (2005) 1621-1628
22. Shea B., Wells G., Cranney A., et al. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocrine Reviews 23 (2002) 552-559
23. Avenell A., Gillespie W.J., Gillespie L.D., and O'Connell D.L. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 18 2 (2005) CD001880
24. Lips P., Graafmans W.C., Ooms M.E., et al. Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 124 (1996) 400-406
25. Meyer H.E., Smedshaug G.B., Kvaavik E., et al. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 17 (2002) 709-715
26. European Commission. Report on osteoporosis in the European Community - Action for prevention. Luxembourg: Office for official publications of the European Communities (1998)
27. Vieth E. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69 (1999) 842-856
28. Taylor R.L., Lynch H.J., and Wysor W.G. Seasonal influence of sunlight on the hypercalcemia of sarcoidosis. Am J Med 34 (1963) 221-227
29. Shai Florence, Baker R., Adrizzo J.R., et al. Hyperalcaemia in mycobacterial infection. J Clin Endocrinol 34 (1972) 251-256
30. Haussler M.R., and McCain T.A. Basic and clinical concepts related to vitamin D metabolism and action. N Engl J Med 297 (1977) 1041-1050
31. de Boer I.H., Ioannou G.N., Kestenbaum B., Brunzell J.D., and Weiss N.S. 25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50 (2007) 69-77
32. Hsia J., Heiss G., Ren H., et al. Women's health initiative investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 115 (2007) 846-854
33. Bone H.G., Hosking D., Devogelaer J.P., et al. Ten years experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350 (2004) 1189-1199
34. Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
35. Harris S.T., Watts N.B., Genant H.K., et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. JAMA 282 (1999) 1352
36. Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 282 (1999) 637-645
37. Chesnut C.H., Silverman S., Andriano K., et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 109 (2000) 267-276
38. Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
39. Delmas P.D., Ensrud K.E., Adachi J.D., et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87 (2002) 3609-3617
40. Mastaglia S.R., Pellegrini G.G., Mandalunis P.M., et al. Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats. Bone 39 (2006) 837-844